Trending, unpaywalled analysis
Faraday has rallied 66% on short covering. The EV start-up has 3 quarters of cash left & stated it needs financing worth 2x its market cap. Delisting is still a risk.
Continuous portfolio rejuvenation has helped Roche to more than offset the sales erosion caused by biosimilar competition. This year, the company has launched one new drug, two more to follow.
Medytox has initiated a legal battle against Hugel, accusing Hugel of stealing its botulinum toxin strains and production methods. This may delay Hugel’s plan to enter the U.S. market this year.
RSVP to join upcoming events. Subscribe for recordings
Today, 5pm SGT, join our Webinar with Analyst Patrick Liao, who will outline his picks among Greater China semiconductor companies and explore the outlook for 2022 and beyond.
On 7 June, 5pm SGT, join our Corporate Webinar featuring Hyphens Pharma Chairman & CEO Mr. Lim See Wah, speaking to Analyst Tina Banerjee and answering audience questions.
On 21 June, 5pm SGT, join our Corporate Webinar with Daniel Phua and Varun Khanna of Siloam Hospitals, talking to Analyst Angus Mackintosh and answering audience questions.
Top tweets of the week